Invesco Dynamic Pharmaceuticals ETF (PJP)
|Ex-Dividend Date||Sep 19, 2022|
|Day's Range||70.06 - 70.91|
|Inception Date||Jun 23, 2005|
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Top 10 Holdings55.23% of assets
|Johnson & Johnson||JNJ||5.98%|
|Eli Lilly and Company||LLY||5.89%|
|Merck & Co.||MRK||5.74%|
|Bausch Health Companies Inc||BHC.TO||4.79%|
|Sep 19, 2022||$0.169||Sep 23, 2022|
|Jun 21, 2022||$0.20676||Jun 30, 2022|
|Mar 21, 2022||$0.20153||Mar 31, 2022|
|Dec 20, 2021||$0.1845||Dec 31, 2021|
|Sep 20, 2021||$0.175||Sep 30, 2021|
|Jun 21, 2021||$0.14784||Jun 30, 2021|
Sector ETF report for PJP
Smart Beta ETF report for PJP
Pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They have to be.
The S&P 500 Health Care Index is up 18% year-to-date, an admiral though not spectacular performance. While coronavirus vaccines remain a point of much discussion, pharmaceuticals stocks also fit the bil...
The Invesco Dynamic Pharmaceuticals ETF (NYSEArca: PJP) is off 3.66% month-to-date, and the source of that lethargy is easy to spot: The drug price reform debate is once again gaining momentum, promptin...
The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs. The Invesco Dynamic Pharmaceuticals ETF (NYSEArca:...
Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.